Log in
Enquire now
‌

US Patent 11964971 Methods and compositions for modulating splicing

Patent 11964971 was granted and assigned to Skyhawk Therapeutics on April, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Skyhawk Therapeutics
Skyhawk Therapeutics
0
Date Filed
July 29, 2021
0
Date of Patent
April 23, 2024
0
Patent Applicant
Skyhawk Therapeutics
Skyhawk Therapeutics
0
Patent Application Number
17388100
0
Patent Citations
‌
US Patent 7399765 Substituted diazabicycloalkane derivatives
0
‌
US Patent 7528132 Kinase inhibitors
0
‌
US Patent 7655657 Fused bicycloheterocycle substituted quinuclidine derivatives
0
‌
US Patent 7674794 Fused bicycloheterocycle substituted quinuclidine derivatives
0
‌
US Patent 7834178 Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
0
‌
US Patent 7838657 Spinal muscular atrophy (SMA) treatment via targeting of
0
‌
US Patent 7872017 Fused bicycloheterocycle substituted azabicyclic alkane derivatives
0
‌
US Patent 7902222 Biaryl substituted azabicyclic alkane derivatives
0
‌
US Patent 7919514 Thiadiazole compounds and methods of use
0
‌
US Patent 7973015 Induction of exon skipping in eukaryotic cells
0
•••
Patent Inventor Names
Brian Lucas
0
Jun Feng
0
Tiansheng Wang
0
Michael Luzzio
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11964971
0
Patent Primary Examiner
‌
Susanna Moore
0
CPC Code
‌
C07D 519/00
0
‌
C07D 498/08
0
‌
C07D 451/06
0
‌
C07D 451/14
0

Find more entities like US Patent 11964971 Methods and compositions for modulating splicing

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.